Benefits of pooled pathogen-inactivated plasma
With the introduction of evidence-based transfusion guidelines part of 1 unit plasma is reduced to less than 5%. The plasma is pooled in the recipient body. There is a technical solution for pathogen inactivation in the pool of donor plasma. Intercept technology for pathogen inactivation in the pooled units of donor plasma reduces the cost of blood bank: within two units at 114.7-189.8%, and within three units at 383.2-552.0%. Regulation for pooling of blood products is necessary to provide for adjusting the technical regulations on the safety of blood.